Orthofix Medical Inc. (NASDAQ:OFIX) Shares Acquired by Engine Capital Management LP

Engine Capital Management LP raised its holdings in shares of Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 2.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,450,744 shares of the medical device company's stock after purchasing an additional 82,079 shares during the quarter. Orthofix Medical accounts for approximately 11.0% of Engine Capital Management LP's investment portfolio, making the stock its largest holding. Engine Capital Management LP owned approximately 9.03% of Orthofix Medical worth $60,250,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Barclays PLC boosted its holdings in Orthofix Medical by 38.8% in the third quarter. Barclays PLC now owns 122,472 shares of the medical device company's stock worth $1,912,000 after acquiring an additional 34,210 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Orthofix Medical by 480.7% in the third quarter. JPMorgan Chase & Co. now owns 84,379 shares of the medical device company's stock valued at $1,318,000 after acquiring an additional 69,848 shares during the period. SG Americas Securities LLC lifted its holdings in Orthofix Medical by 24.3% in the fourth quarter. SG Americas Securities LLC now owns 21,279 shares of the medical device company's stock valued at $372,000 after acquiring an additional 4,162 shares during the period. Kirr Marbach & Co. LLC IN acquired a new position in Orthofix Medical in the fourth quarter valued at approximately $532,000. Finally, R Squared Ltd acquired a new position in Orthofix Medical in the fourth quarter valued at approximately $50,000. 89.76% of the stock is currently owned by institutional investors.

Insider Transactions at Orthofix Medical

In other Orthofix Medical news, CEO Massimo Calafiore bought 10,000 shares of the business's stock in a transaction dated Friday, May 9th. The shares were acquired at an average price of $12.54 per share, with a total value of $125,400.00. Following the transaction, the chief executive officer now owns 234,603 shares of the company's stock, valued at approximately $2,941,921.62. The trade was a 4.45% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, major shareholder Engine Capital Management, Lp bought 100,000 shares of the business's stock in a transaction dated Wednesday, May 7th. The shares were acquired at an average cost of $12.31 per share, for a total transaction of $1,231,000.00. Following the transaction, the insider now directly owns 3,544,807 shares in the company, valued at approximately $43,636,574.17. This represents a 2.90% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders sold 8,475 shares of company stock worth $128,065. 2.60% of the stock is currently owned by company insiders.

Orthofix Medical Price Performance

Shares of Orthofix Medical stock traded down $0.45 on Wednesday, reaching $12.04. The company's stock had a trading volume of 149,612 shares, compared to its average volume of 260,227. The company has a market capitalization of $469.82 million, a P/E ratio of -3.85 and a beta of 0.87. Orthofix Medical Inc. has a 52-week low of $10.50 and a 52-week high of $20.73. The stock has a 50-day moving average price of $14.68 and a 200-day moving average price of $16.87. The company has a quick ratio of 1.11, a current ratio of 2.39 and a debt-to-equity ratio of 0.25.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on OFIX shares. Canaccord Genuity Group reissued a "buy" rating and issued a $24.00 price target on shares of Orthofix Medical in a report on Wednesday, February 26th. Roth Mkm reissued a "buy" rating and issued a $22.00 price target on shares of Orthofix Medical in a report on Wednesday, February 26th. Finally, StockNews.com cut Orthofix Medical from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.